Pharmaceuticals Global On demand · 24-48h

Global Supplements for Hormone Balance Market Strategic Research Report

Global Supplements for Hormone Balance Market Strategic Rese…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Supplements for Hormone Balance Market
$3.16B2025
8.4%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Capsule Type, Tablet Form, Other

By Application: Pharmacies & Drugstores, Online Retail, Direct-to-Consumer, Specialty Health Stores

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Life Extension, Rejuvenated, Pure Encapsulations, MW Nutrition, Biote, 1Up Nutrition, VitaBright, Natural Medicine, S'moo, The Health & Her, DaVinci Laboratories, Garden of Life, New Chapter, Nutrigold, Gaia Herbs, Thorne Research, MegaFood, NOW Foods, Jarrow Formulas

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 145 pages
Market size 2025
$3.16B
Billion USD
Forecast CAGR
8.4%
2025-2032
Forecast 2032
$5.6B
Projected
Области
5
Asia Pacific · Latin America · MEA · Europe · North America

Обзор

Scope of the Report

The global Supplements for Hormone Balance market size is predicted to grow from US$ 3,160 million in 2025 to US$ 5,538 million in 2032; it is expected to grow at a CAGR of 8.4% from 2026 to 2032.

Supplements for hormone balance refer to dietary supplement products formulated to support endocrine regulation and hormonal stability, commonly targeting estrogen, progesterone, testosterone, cortisol, thyroid-related balance, and stress-associated hormonal responses. These products typically contain vitamins, minerals, botanical extracts, amino acids, and functional compounds such as adaptogens, phytoestrogens, or micronutrients, and are sold in capsule, tablet, powder, or liquid forms. From a value chain perspective, upstream activities include raw materials such as botanical extracts, vitamins, minerals, amino acids, and excipients, midstream processes focus on formulation development, blending, encapsulation or tableting, quality control, and packaging, while downstream demand is driven by dietary supplement brands, pharmacies, online retailers, wellness clinics, and direct-to-consumer platforms. In 2025, the average selling price of supplements for hormone balance is approximately US$38 per unit, with global sales volume reaching around 85 million units. The industry maintains a gross margin of 55%–70%, supported by brand-driven pricing, high consumer willingness to pay, recurring consumption patterns, and expanding demand for personalized wellness solutions.

The market for supplements for hormone balance has been experiencing significant growth in recent years. This can be attributed to several factors:1. Increasing awareness of hormone imbalances: More people are becoming aware of the impact that hormonal imbalances can have on overall health and well-being. This increased awareness has led to a greater demand for supplements that can help support hormone balance.2. Rising prevalence of hormonal issues: Hormonal imbalances are becoming more common due to various factors such as stress, poor diet, environmental toxins, and lifestyle choices. As a result, there is a growing need for supplements that can help regulate hormones and promote balance.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Supplements for Hormone Balance market?

What factors are driving Supplements for Hormone Balance market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Supplements for Hormone Balance market opportunities vary by end market size?

How does Supplements for Hormone Balance break out by Type, by Application?

This report presents a comprehensive overview of the global Supplements for Hormone Balance market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Capsule Type
  • Tablet Form
  • Other

Segment by Target Hormone

  • Estrogen Balance
  • Progesterone Support
  • Testosterone Support
  • Cortisol & Stress Balance
  • Thyroid Support

Segment by Consumer Group

  • Women’s Health
  • Men’s Health
  • Aging Population

Segment by Application

  • Pharmacies & Drugstores
  • Online Retail
  • Direct-to-Consumer
  • Specialty Health Stores

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Supplements for Hormone Balance market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Pharmacies & Drugstores, Online Retail, Direct-to-Consumer evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Supplements for Hormone Balance Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 8.4%
Regional growth momentum
Market share by segment
Key metrics
Base value
$3.16B
2025
Forecast
$5.6B
2032
CAGR
8.4%
2025–2032
Области
5
global
Key companies
Life ExtensionRejuvenatedPure EncapsulationsMW NutritionBiote1Up NutritionVitaBrightNatural Medicine
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Capsule TypeTablet FormOther
By Application
Pharmacies & DrugstoresOnline RetailDirect-to-ConsumerSpecialty Health Stores

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Capsule Type
  • 3.1.3 Tablet Form
  • 3.1.4 Other
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Pharmacies & Drugstores
  • 4.1.3 Online Retail
  • 4.1.4 Direct-to-Consumer
  • 4.1.5 Specialty Health Stores
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Life Extension
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Rejuvenated
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Pure Encapsulations
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 MW Nutrition
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Biote
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 1Up Nutrition
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 VitaBright
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Natural Medicine
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 S'moo
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 The Health & Her
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 DaVinci Laboratories
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Garden of Life
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 New Chapter
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Nutrigold
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Gaia Herbs
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Thorne Research
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 MegaFood
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 NOW Foods
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Jarrow Formulas
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Supplements for Hormone Balance market size?
The global Supplements for Hormone Balance market is estimated at US$ 3.16 billion in 2025 (base year) and is projected to reach US$ 5.54 billion by 2032.
What growth rate is expected for the Supplements for Hormone Balance market through 2032?
The market is expected to grow at a CAGR of 8.4% from 2026 to 2032, expanding from US$ 3.16 billion in 2025 to US$ 5.54 billion in 2032, roughly 1.8 times its base-year value.
How is Supplements for Hormone Balance defined?
Supplements for hormone balance refer to dietary supplement products formulated to support endocrine regulation and hormonal stability, commonly targeting estrogen, progesterone, testosterone, cortisol, thyroid-related balance, and stress-associated hormonal responses. These products typically contain vitamins, minerals, botanical extracts, amino acids, and functional compounds such as adaptogens, phytoestrogens, or micronutrients, and are sold in capsule, tablet, powder, or liquid forms.
What are the main segments of the Supplements for Hormone Balance market by type?
By type, the market is segmented into Capsule Type, Tablet Form and Other.
Which applications drive demand in the Supplements for Hormone Balance market?
Key applications covered include Pharmacies & Drugstores, Online Retail, Direct-to-Consumer and Specialty Health Stores.
Who are the key players in the Supplements for Hormone Balance market?
Key players profiled include Life Extension, Rejuvenated, Pure Encapsulations, MW Nutrition, Biote, 1Up Nutrition, VitaBright and Natural Medicine, among 19 companies covered in total.
Which regions and countries are covered for Supplements for Hormone Balance?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Supplements for Hormone Balance market?
What factors are driving Supplements for Hormone Balance market growth, globally and by region?
Who should buy the Supplements for Hormone Balance market report?
The report is intended for manufacturers and solution providers, distributors and end users in Pharmacies & Drugstores, Online Retail and Direct-to-Consumer, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Supplements for Hormone Balance market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3 500,00 $
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.